Pharma Partnerships Flocel’s DIV-BBB dynamic in vitro blood-brain barrier model offers a credible platform for CNS drug screening, creating a compelling entry point to partner with pharmaceutical companies and CROs for early-stage BBB assays and neurotoxicity testing.

Geographic Expansion With existing footprints in the US and Europe, Flocel can accelerate growth by engaging regional distributors or OEM partners in neuroscience labs and contract research, extending the reach of DIV-BBB products without steep new investments.

Data and Analytics A modern data layer and hosted results workflows could differentiate Flocel by offering cloud-enabled assay tracking, benchmarks, and technical support, helping customers compare studies and scale their use of DIV-BBB.

Academic Partnerships The Cleveland Clinic licensing heritage provides credibility for university collaborations and joint development projects, enabling opportunities to co-develop new models or validate DIV-BBB across academic labs.

Turnkey Solutions Flocel can monetize its niche through value-added services such as training, on-site consultation, custom model development, and ongoing technical support to CROs and labs building BBB capabilities.